Cancer Patient Lab Meetings
Upcoming Meetings
- November 29: “Testing and Treatment Options Review for Ian Lewington”
- December 6, 7:00 pm Eastern: Matthew Dons, Director, Make Cancer History, on “International Efforts and Japanese Resources to Fight Cancer”
- January 3, 2024: “Navigating Brain Cancer” (Al Musella)
- January 10, 2024: “Translating Patient Data into Clinical Use”, Eliezer M. Van Allen, M.D., Associate Professor of Medicine, Harvard Medical School, Chief, Division of Population Sciences, Dana-Farber Cancer Institute, Department of Medical Oncology, Dana-Farber Cancer Institute, Institute Member, Broad Institute
- To be scheduled: Saul Priceman, PhD, City of Hope, “Update on Immunotherapies (CARs and BiTEs) for Solid Tumors”
- To be scheduled: Carrie Stricker, “Improving Cancer Care through Learning Health Networks”
- To be scheduled: Andrew Rech, MD, PhD, Post-Doctoral Research Fellow, University of Pennsylvania, Department of Pathology and Laboratory Medicine, Laboratory of Carl H. June, “Understanding the Prostate Tumor Microenvironment with Spatial and Single Cell Analysis for Immunotherapies (Round Two)”
- To be scheduled: “Rapid Functional Testing Using Ex Vivo 3D Cell Culture Technology”, Matt Gevaert, PhD, CEO, and Eric Perreault, President, Kiyatec
- To be scheduled: Gary Onik, MD, “Using Ultrasound to Guide Extreme Cold Treatment for Cancer”
Previous Meetings
Learning Sessions
- #77: “Finding Personalized Cancer Treatments Beyond the Standard through a Unique Test”, Dennis Watson, VP of Business Development, Travera
- #76: “Opening up Access to Cancer Data for Patients”, Frank Nothaft, PhD
- #75: Katerina Postovalova, PhD, BostonGene Head of Digital Pathology, on “Inside an Advanced Testing Lab and Bioinformatics”
- #74: Jeff Krolick and Robert Ellis, advanced prostate cancer patients; Manish Agrawal, MD, director of Sunstone Therapies, and Rebecca Ehrenkranz, PhD, postdoc at Johns Hopkins Center for Psychedelic and Consciousness Research, “Using Psychedelics for Managing Existential Anxiety and Mortality”
- #73: Chris Beardmore, CEO & Co-Founder, Anova Enterprises, Inc., on “Getting Access to Your Cancer Treatment”
- #72: Michael Hensley, Sr. Strategic Account Manager, and Michelle Lanman, BostonGene, on “The BostonGene Tumor Portrait Report and How to Access It"
- #71: Mark Taylor, Founder, Patient Led Oncology, “A Cancer Hacker Solves His Own Needs and Helps Others Access the Best, New, Personalized Tests and Treatments”
- #70: “Guiding personalized treatment for prostate cancer (Round Two)”, Andy Armstrong, MD
- #69: "Permission to be Pissed", Matthew Zachary, Principal, Matthew Zachary Worldwide; Founder and Chair, OffScrip Health; Host, “Out of Patients with Matthew Zachary” – on Americans who are gaming the medical system
- #68: “Personalized Drug Dosing for Advanced Cancer”, Paul Van Camp, MD, and Jeff Krolick
- #67: Yuval Gal, CEO, and Tal Salman, co-founders of Berries, “Introducing an app for navigating cancer care”
- #66: Sumit Subhudi, MD, PhD, “Update on Immunotherapies for Metastatic Castrate Resistant Prostate Cancer”
- #64: Andy Armstrong, MD, “Using digital pathology, liquid biopsies, and AI solutions to guide personalized treatment for prostate cancer”
- #63: Andrew Rech, MD, PhD, Post-Doctoral Research Fellow, University of Pennsylvania, Department of Pathology and Laboratory Medicine, Laboratory of Carl H. June, “Immunotherapies at a Turning Point - Understand the Tumor Microenvironment?”
- #62: Oliver Sartor, MD, Mayo Clinic, “The Current and Future Landscape of Metastatic Castrate Resistant Prostate Cancer”
- #61: Lauren Cohen, DC, Managing Director of RGCC International - North America and Members of the RGCC Clinical and Scientific Team, on "Novel Testing to Guide Personalized Cancer Treatment"
- #60: MIchael Donohoo, advanced prostate cancer patient, “Keeping Family and Friends Informed about My Disease Using a Software Service”
- #59: Edward Friedman, PhD, Biophysics and Theoretical Biology, University of Chicago, “How Hormone Receptors Affect Prostate Cancer”
- #58: Russ Hollyer, advanced prostate cancer patient, “How I Am Running Experiments on Myself to Control My Prostate Cancer – Using Bipolar Androgen Therapy”
- Prostate Cancer Lab #57: Developments in Radiation for Cancer Care (Carl Rossi)
- Prostate Cancer Lab #56: “Bipolar Androgen Therapy for Prostate Cancer" (Emmanuel Antonarakis)
- Prostate Cancer Lab #55: “Pluvicto” (Brian McCloskey)
Patient Updates
- #71: Mark Taylor, Founder, Patient Led Oncology, “A Cancer Hacker Solves His Own Needs and Helps Others Access the Best, New, Personalized Tests and Treatments”
- #65: Jeff Dwyer, advanced prostate cancer patient, “Treating My Osteoporosis and My Prostate Cancer”